Orexo is a Sweden-based specialty pharmaceutical company that develops and commercial drugs for the treatment of opioid dependence.
Business Model:
Revenue: $61.6M
Employees: 51-200
Address: P.O. Box 303
City: Uppsala
State: uppsala län
Zip: 751 05
Country: SE
Orexo is a Sweden-based specialty pharmaceutical company that develops and commercial drugs for the treatment of opioid dependence.
Contact Phone:
Contact Email:
Listed Exchange:
SIX Swiss Exchange
IPO Date:
11/18/2005
Ticker Symbol:
ORX
Amount Raised:
$42M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2014 | Post-IPO Equity | $50.6M | 1/2003 | Series B | 5 | $22.4M |
Apex Venture Partners Crédit Lyonnais Private Equity HealthCap Sofinnova Investments Auriga Partners Apex Venture Partners Crédit Lyonnais Private Equity HealthCap Sofinnova Investments Auriga Partners |
4/2010 | Post-IPO Equity | 1 | - |
Novo Holdings Novo Holdings |
4/2010 | Post-IPO Equity | 1 | - |
Novo Holdings Novo Holdings |
1/2003 | Series B | 5 | $22.4M |
Apex Venture Partners Crédit Lyonnais Private Equity HealthCap Sofinnova Investments Auriga Partners Apex Venture Partners Crédit Lyonnais Private Equity HealthCap Sofinnova Investments Auriga Partners |
---|
Announced Date | Name | Price |
---|---|---|
2/2009 | PharmaKodex | |
11/2007 | Biolipox |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|